Publication | Closed Access

Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens

Cholecystokinin AntagonistMedicinePhysiologyNeuropharmacologyNeuroscienceNucleus AccumbensDark-induced HyperlocomotionNervous SystemPharmacologyGastrointestinal Peptide Hormone